Stock comparison
Side-by-side financials for BNGO and A. Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
A is larger
Market cap data is available for the leading company in this comparison.
Market value leader
A
Latest market capitalization comparison.
Revenue leader
A
BNGO: $28.51M vs A: $6.95B.
Profit leader
A
BNGO: -$26.39M vs A: $1.30B.
Margin leader
A
BNGO: -92.6% vs A: 18.8% net margin.
| Metric | BNGO | A |
|---|---|---|
| Market cap | - | $37.76 B |
| US-listed rank | - | #405 |
| Revenue (latest FY) | $28.51M | $6.95B |
| Net income (latest FY) | -$26.39M | $1.30B |
| Net margin | -92.6% | 18.8% |
| P/E (trailing FY) | - | 29.0x |
| SEC filings | 603 | 2,339 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
In their latest fiscal years, Bionano Genomics, Inc. reported $28.51M in revenue while AGILENT TECHNOLOGIES, INC. reported $6.95B.
Full pages: Bionano Genomics, Inc. and AGILENT TECHNOLOGIES, INC., or browse the full rankings.